Press Releases

• May. 8, 2008
  Insmed Announces First Quarter 2008 Financial Results Read More
• May. 8, 2008
  /C O R R E C T I O N -- Insmed Inc./ Read More

Follow-On Biologics

• What are Follow-On Biologics?
• Creating a Pathway
• Latest Developments
• Insmed's Role
• Unique Positioning
• Capabilities

Focusing on Markets with Unmet Needs

Insmed is a research-driven biopharmaceutical company with broad expertise in and innovative approaches to the development of protein-based therapeutics, and efficiently moving product candidates through the regulatory approval process.

Learn more about us

Generic Biological Treatments and the Associated Cost Savings

Inside Insmed's Biologics Facility
(video)

Read the American.com Interview with Insmed CEO Geoffrey Allan